TechTarget, Inc.

For the period ended Mar 31, 2025. Filed Jul 14, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed Jul 14, 2025

TTGT$3.02+14.6%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Item 1. Financial Statements

PART I. FINANCIAL INFORMATION

Unaudited Condensed Consolidated Balance Sheets

(in thousands, except share and per share data)

	March 31, 2025	December 31, 2024
Assets
Current assets:
Cash and cash equivalents	$78,656	$275,983
Short-term investments	—	77,705
Accounts receivable, net of allowance for credit losses of $1,219 and $907 respectively	68,099	79,039
Related party receivables	5,103	2,900
Prepaid taxes	7,125	6,443
Prepaid expenses and other current assets	15,519	13,547
Total current assets	174,502	455,617
Non-current assets:
Property and equipment, net	4,127	4,621
Goodwill	515,510	973,398
Intangible assets, net	789,200	808,732
Operating lease right-of-use assets	14,766	15,907
Deferred tax assets	5,095	5,097
Other non-current assets	2,920	3,115
Total non-current assets	1,331,618	1,810,870
Total assets	$1,506,120	$2,266,487
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable	$8,949	$10,639
Related party payables	15,229	4,795
Contract liabilities	54,441	44,825
Operating lease liabilities	5,202	5,186
Accrued expenses and other current liabilities	23,237	29,328
Accrued compensation expenses	16,019	18,093
Income taxes payable	59,780	6,701
Convertible debt	—	415,690
Total current liabilities	182,857	535,257
Non-current liabilities:
Operating lease liabilities	13,614	15,107
Other liabilities	5,327	4,913
Related party revolving line of credit	135,000	—
Deferred tax liabilities	112,907	139,356
Total non-current liabilities	266,848	159,376
Total liabilities	$449,705	$694,633
Stockholders’ equity:
Common stock, $0.001 par value; 250,000,000 shares authorized; 71,485,181 shares issued and outstanding at March 31, 2025; 71,460,169 shares issued and outstanding at December 31, 2024	71	71
Additional paid-in capital	1,630,744	1,626,785
Retained deficit	(599,325)	(75,937)
Accumulated other comprehensive income	24,925	20,935
Total stockholders’ equity	1,056,415	1,571,854
Total liabilities and stockholders’ equity	$1,506,120	$2,266,487

Unaudited Condensed Consolidated Statements of Income (Loss) and Comprehensive Income (Loss)

(in thousands, except per share data)

	For the Three Months Ended
	March 31, 2025	March 31, 2024
As Restated
Revenues1	$103,887	$58,659
Cost of revenues1,2	(44,160)	(23,969)
Gross profit	59,727	34,690
Operating expenses:
Selling and marketing2	33,310	13,807
General and administrative1,2	24,284	18,178
Product development2	2,789	3,019
Depreciation	532	403
Amortization, excluding amortization of $2,473, and $102 included in cost of revenues	23,288	10,836
Impairment of goodwill	459,100	—
Impairment of long-lived assets	—	1,864
Acquisition and integration costs1	9,328	6,977
Remeasurement of contingent consideration	—	2,064
Total operating expenses	552,631	57,148
Operating loss	(492,904)	(22,458)
Related party interest expense	(1,813)	(6,201)
Interest income1	826	1,234
Other income (expense), net	(3,094)	218
Loss before provision for income taxes	(496,985)	(27,207)
Income tax benefit (provision)	(26,403)	7,698
Net loss	$(523,388)	$(19,509)
Other comprehensive income, net of tax:
Foreign currency translation gain	3,990	2,551
Total comprehensive loss	$(519,398)	$(16,958)
Net loss per common share:
Basic	(7.32)	(0.47)
Diluted	(7.32)	(0.47)
Weighted average common shares outstanding:
Basic	71,465,493	41,651,366
Diluted	71,465,493	41,651,366
(1) Amounts include related party transactions as follows:
Revenues	224	84
Cost of revenues	277	—
General and administrative	6,279	8,505
Interest income	—	1,029
Acquisition and integration costs	46	6,055
(2) Amounts include stock-based compensation expense as follows:
Cost of revenues	308	—
Selling and marketing	2,757	—
General and administrative	711	266
Product development	183	—

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.